nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—Alzheimer's disease	0.571	1	CbGaD
Risedronate—FDPS—Cholesterol biosynthesis—DHCR24—Alzheimer's disease	0.0138	0.211	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—AMFR—Alzheimer's disease	0.00728	0.112	CbGpPWpGaD
Risedronate—Histamine Phosphate—CA4—Alzheimer's disease	0.00338	0.801	CrCbGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—RCAN1—Alzheimer's disease	0.002	0.0308	CbGpPWpGaD
Risedronate—FDPS—forebrain—Alzheimer's disease	0.00199	0.152	CbGeAlD
Risedronate—FDPS—telencephalon—Alzheimer's disease	0.00183	0.14	CbGeAlD
Risedronate—FDPS—SREBP signalling—GSK3A—Alzheimer's disease	0.00157	0.0242	CbGpPWpGaD
Risedronate—PTGS2—blood vessel—Alzheimer's disease	0.00145	0.111	CbGeAlD
Risedronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—Alzheimer's disease	0.00143	0.0219	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—PTGS1—Alzheimer's disease	0.00112	0.0172	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—LPL—Alzheimer's disease	0.00111	0.017	CbGpPWpGaD
Risedronate—FDPS—nervous system—Alzheimer's disease	0.00108	0.0826	CbGeAlD
Risedronate—FDPS—central nervous system—Alzheimer's disease	0.00104	0.0796	CbGeAlD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.00102	0.0157	CbGpPWpGaD
Risedronate—FDPS—cerebellum—Alzheimer's disease	0.00102	0.0778	CbGeAlD
Risedronate—PTGS2—Eicosanoid Synthesis—PTGS1—Alzheimer's disease	0.000928	0.0142	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SERPINA3—Alzheimer's disease	0.000925	0.0142	CbGpPWpGaD
Risedronate—PTGS2—embryo—Alzheimer's disease	0.000864	0.066	CbGeAlD
Risedronate—Histamine Phosphate—CYP2D6—Alzheimer's disease	0.000838	0.199	CrCbGaD
Risedronate—FDPS—brain—Alzheimer's disease	0.000827	0.0632	CbGeAlD
Risedronate—PTGS2—Overview of nanoparticle effects—HMOX1—Alzheimer's disease	0.000816	0.0125	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—PPARG—Alzheimer's disease	0.000811	0.0124	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—CREB1—Alzheimer's disease	0.0008	0.0123	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—INS—Alzheimer's disease	0.000795	0.0122	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—Alzheimer's disease	0.000776	0.0119	CbGpPWpGaD
Risedronate—Bronchitis—Donepezil—Alzheimer's disease	0.000772	0.00223	CcSEcCtD
Risedronate—Abdominal discomfort—Donepezil—Alzheimer's disease	0.000769	0.00222	CcSEcCtD
Risedronate—Cardiac disorder—Galantamine—Alzheimer's disease	0.000769	0.00222	CcSEcCtD
Risedronate—PTGS2—forebrain—Alzheimer's disease	0.000764	0.0583	CbGeAlD
Risedronate—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.000761	0.0022	CcSEcCtD
Risedronate—Nasopharyngitis—Memantine—Alzheimer's disease	0.000754	0.00218	CcSEcCtD
Risedronate—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.000753	0.00217	CcSEcCtD
Risedronate—Angiopathy—Galantamine—Alzheimer's disease	0.000752	0.00217	CcSEcCtD
Risedronate—Immune system disorder—Galantamine—Alzheimer's disease	0.000749	0.00216	CcSEcCtD
Risedronate—Gastritis—Memantine—Alzheimer's disease	0.000746	0.00215	CcSEcCtD
Risedronate—Breast disorder—Rivastigmine—Alzheimer's disease	0.000745	0.00215	CcSEcCtD
Risedronate—Muscular weakness—Memantine—Alzheimer's disease	0.000743	0.00215	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—BAX—Alzheimer's disease	0.000741	0.0114	CbGpPWpGaD
Risedronate—Arrhythmia—Galantamine—Alzheimer's disease	0.00074	0.00214	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000738	0.0113	CbGpPWpGaD
Risedronate—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000737	0.00213	CcSEcCtD
Risedronate—Gastritis—Rivastigmine—Alzheimer's disease	0.00073	0.00211	CcSEcCtD
Risedronate—Asthma—Memantine—Alzheimer's disease	0.000729	0.0021	CcSEcCtD
Risedronate—Influenza—Memantine—Alzheimer's disease	0.000729	0.0021	CcSEcCtD
Risedronate—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000727	0.0021	CcSEcCtD
Risedronate—Mental disorder—Galantamine—Alzheimer's disease	0.000726	0.0021	CcSEcCtD
Risedronate—Malnutrition—Galantamine—Alzheimer's disease	0.000721	0.00208	CcSEcCtD
Risedronate—Pneumonia—Donepezil—Alzheimer's disease	0.00072	0.00208	CcSEcCtD
Risedronate—Infestation NOS—Donepezil—Alzheimer's disease	0.000715	0.00207	CcSEcCtD
Risedronate—Infestation—Donepezil—Alzheimer's disease	0.000715	0.00207	CcSEcCtD
Risedronate—Depression—Donepezil—Alzheimer's disease	0.000713	0.00206	CcSEcCtD
Risedronate—Flatulence—Galantamine—Alzheimer's disease	0.000711	0.00205	CcSEcCtD
Risedronate—Angina pectoris—Memantine—Alzheimer's disease	0.00071	0.00205	CcSEcCtD
Risedronate—PTGS2—telencephalon—Alzheimer's disease	0.000703	0.0536	CbGeAlD
Risedronate—Bronchitis—Memantine—Alzheimer's disease	0.000701	0.00202	CcSEcCtD
Risedronate—Back pain—Galantamine—Alzheimer's disease	0.000698	0.00201	CcSEcCtD
Risedronate—Urinary tract infection—Donepezil—Alzheimer's disease	0.000695	0.00201	CcSEcCtD
Risedronate—Conjunctivitis—Donepezil—Alzheimer's disease	0.000695	0.00201	CcSEcCtD
Risedronate—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000694	0.002	CcSEcCtD
Risedronate—Muscle spasms—Galantamine—Alzheimer's disease	0.000694	0.002	CcSEcCtD
Risedronate—Bronchitis—Rivastigmine—Alzheimer's disease	0.000685	0.00198	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000681	0.0104	CbGpPWpGaD
Risedronate—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000677	0.00195	CcSEcCtD
Risedronate—Anaemia—Galantamine—Alzheimer's disease	0.000667	0.00192	CcSEcCtD
Risedronate—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000662	0.00191	CcSEcCtD
Risedronate—Pneumonia—Memantine—Alzheimer's disease	0.000653	0.00189	CcSEcCtD
Risedronate—Infestation—Memantine—Alzheimer's disease	0.00065	0.00188	CcSEcCtD
Risedronate—Infestation NOS—Memantine—Alzheimer's disease	0.00065	0.00188	CcSEcCtD
Risedronate—Vertigo—Galantamine—Alzheimer's disease	0.000648	0.00187	CcSEcCtD
Risedronate—Depression—Memantine—Alzheimer's disease	0.000648	0.00187	CcSEcCtD
Risedronate—Syncope—Galantamine—Alzheimer's disease	0.000647	0.00187	CcSEcCtD
Risedronate—Haemoglobin—Donepezil—Alzheimer's disease	0.000646	0.00186	CcSEcCtD
Risedronate—Rhinitis—Donepezil—Alzheimer's disease	0.000644	0.00186	CcSEcCtD
Risedronate—Haemorrhage—Donepezil—Alzheimer's disease	0.000642	0.00185	CcSEcCtD
Risedronate—Pneumonia—Rivastigmine—Alzheimer's disease	0.000639	0.00185	CcSEcCtD
Risedronate—Pharyngitis—Donepezil—Alzheimer's disease	0.000637	0.00184	CcSEcCtD
Risedronate—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000635	0.00183	CcSEcCtD
Risedronate—Infestation—Rivastigmine—Alzheimer's disease	0.000635	0.00183	CcSEcCtD
Risedronate—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000634	0.00183	CcSEcCtD
Risedronate—Loss of consciousness—Galantamine—Alzheimer's disease	0.000634	0.00183	CcSEcCtD
Risedronate—Depression—Rivastigmine—Alzheimer's disease	0.000634	0.00183	CcSEcCtD
Risedronate—Oedema peripheral—Donepezil—Alzheimer's disease	0.000633	0.00183	CcSEcCtD
Risedronate—Urinary tract infection—Memantine—Alzheimer's disease	0.000631	0.00182	CcSEcCtD
Risedronate—Conjunctivitis—Memantine—Alzheimer's disease	0.000631	0.00182	CcSEcCtD
Risedronate—Urethral disorder—Donepezil—Alzheimer's disease	0.00063	0.00182	CcSEcCtD
Risedronate—Cough—Galantamine—Alzheimer's disease	0.00063	0.00182	CcSEcCtD
Risedronate—Hypertension—Galantamine—Alzheimer's disease	0.000623	0.0018	CcSEcCtD
Risedronate—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000618	0.00178	CcSEcCtD
Risedronate—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000618	0.00178	CcSEcCtD
Risedronate—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000614	0.00177	CcSEcCtD
Risedronate—Chest pain—Galantamine—Alzheimer's disease	0.000614	0.00177	CcSEcCtD
Risedronate—Myalgia—Galantamine—Alzheimer's disease	0.000614	0.00177	CcSEcCtD
Risedronate—Arthralgia—Galantamine—Alzheimer's disease	0.000614	0.00177	CcSEcCtD
Risedronate—Anxiety—Galantamine—Alzheimer's disease	0.000612	0.00177	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00061	0.00176	CcSEcCtD
Risedronate—Sinusitis—Memantine—Alzheimer's disease	0.000609	0.00176	CcSEcCtD
Risedronate—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000601	0.00173	CcSEcCtD
Risedronate—Dry mouth—Galantamine—Alzheimer's disease	0.000601	0.00173	CcSEcCtD
Risedronate—Tinnitus—Donepezil—Alzheimer's disease	0.000599	0.00173	CcSEcCtD
Risedronate—Sinusitis—Rivastigmine—Alzheimer's disease	0.000596	0.00172	CcSEcCtD
Risedronate—Haemoglobin—Memantine—Alzheimer's disease	0.000586	0.00169	CcSEcCtD
Risedronate—Rhinitis—Memantine—Alzheimer's disease	0.000585	0.00169	CcSEcCtD
Risedronate—Haemorrhage—Memantine—Alzheimer's disease	0.000583	0.00168	CcSEcCtD
Risedronate—Shock—Galantamine—Alzheimer's disease	0.000579	0.00167	CcSEcCtD
Risedronate—Pharyngitis—Memantine—Alzheimer's disease	0.000579	0.00167	CcSEcCtD
Risedronate—Nervous system disorder—Galantamine—Alzheimer's disease	0.000577	0.00167	CcSEcCtD
Risedronate—Urinary tract disorder—Memantine—Alzheimer's disease	0.000576	0.00166	CcSEcCtD
Risedronate—Oedema peripheral—Memantine—Alzheimer's disease	0.000574	0.00166	CcSEcCtD
Risedronate—Arrhythmia—Donepezil—Alzheimer's disease	0.000574	0.00166	CcSEcCtD
Risedronate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000573	0.00166	CcSEcCtD
Risedronate—Connective tissue disorder—Memantine—Alzheimer's disease	0.000573	0.00165	CcSEcCtD
Risedronate—Rhinitis—Rivastigmine—Alzheimer's disease	0.000572	0.00165	CcSEcCtD
Risedronate—Skin disorder—Galantamine—Alzheimer's disease	0.000572	0.00165	CcSEcCtD
Risedronate—Urethral disorder—Memantine—Alzheimer's disease	0.000572	0.00165	CcSEcCtD
Risedronate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00057	0.00165	CcSEcCtD
Risedronate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000566	0.00163	CcSEcCtD
Risedronate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000563	0.00163	CcSEcCtD
Risedronate—Mental disorder—Donepezil—Alzheimer's disease	0.000563	0.00162	CcSEcCtD
Risedronate—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000562	0.00162	CcSEcCtD
Risedronate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000561	0.00162	CcSEcCtD
Risedronate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000559	0.00161	CcSEcCtD
Risedronate—Malnutrition—Donepezil—Alzheimer's disease	0.000559	0.00161	CcSEcCtD
Risedronate—Flatulence—Donepezil—Alzheimer's disease	0.000551	0.00159	CcSEcCtD
Risedronate—Eye disorder—Memantine—Alzheimer's disease	0.000545	0.00157	CcSEcCtD
Risedronate—Tinnitus—Memantine—Alzheimer's disease	0.000544	0.00157	CcSEcCtD
Risedronate—Cardiac disorder—Memantine—Alzheimer's disease	0.000541	0.00156	CcSEcCtD
Risedronate—Back pain—Donepezil—Alzheimer's disease	0.000541	0.00156	CcSEcCtD
Risedronate—Muscle spasms—Donepezil—Alzheimer's disease	0.000538	0.00155	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000536	0.00155	CcSEcCtD
Risedronate—Eye disorder—Rivastigmine—Alzheimer's disease	0.000533	0.00154	CcSEcCtD
Risedronate—Insomnia—Galantamine—Alzheimer's disease	0.000533	0.00154	CcSEcCtD
Risedronate—Tinnitus—Rivastigmine—Alzheimer's disease	0.000532	0.00154	CcSEcCtD
Risedronate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000529	0.00153	CcSEcCtD
Risedronate—Angiopathy—Memantine—Alzheimer's disease	0.000529	0.00153	CcSEcCtD
Risedronate—Paraesthesia—Galantamine—Alzheimer's disease	0.000529	0.00153	CcSEcCtD
Risedronate—Immune system disorder—Memantine—Alzheimer's disease	0.000527	0.00152	CcSEcCtD
Risedronate—Mediastinal disorder—Memantine—Alzheimer's disease	0.000526	0.00152	CcSEcCtD
Risedronate—Arrhythmia—Memantine—Alzheimer's disease	0.000521	0.0015	CcSEcCtD
Risedronate—Dyspepsia—Galantamine—Alzheimer's disease	0.000518	0.0015	CcSEcCtD
Risedronate—Angiopathy—Rivastigmine—Alzheimer's disease	0.000518	0.00149	CcSEcCtD
Risedronate—Anaemia—Donepezil—Alzheimer's disease	0.000517	0.00149	CcSEcCtD
Risedronate—PTGS2—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.000516	0.00792	CbGpPWpGaD
Risedronate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000514	0.00148	CcSEcCtD
Risedronate—Mental disorder—Memantine—Alzheimer's disease	0.000511	0.00147	CcSEcCtD
Risedronate—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00051	0.00147	CcSEcCtD
Risedronate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000508	0.00147	CcSEcCtD
Risedronate—Malnutrition—Memantine—Alzheimer's disease	0.000508	0.00147	CcSEcCtD
Risedronate—Fatigue—Galantamine—Alzheimer's disease	0.000508	0.00147	CcSEcCtD
Risedronate—Constipation—Galantamine—Alzheimer's disease	0.000503	0.00145	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—PPARGC1A—Alzheimer's disease	0.000503	0.00772	CbGpPWpGaD
Risedronate—Vertigo—Donepezil—Alzheimer's disease	0.000502	0.00145	CcSEcCtD
Risedronate—Syncope—Donepezil—Alzheimer's disease	0.000501	0.00145	CcSEcCtD
Risedronate—Flatulence—Memantine—Alzheimer's disease	0.0005	0.00144	CcSEcCtD
Risedronate—Mental disorder—Rivastigmine—Alzheimer's disease	0.0005	0.00144	CcSEcCtD
Risedronate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000497	0.00143	CcSEcCtD
Risedronate—Loss of consciousness—Donepezil—Alzheimer's disease	0.000491	0.00142	CcSEcCtD
Risedronate—Back pain—Memantine—Alzheimer's disease	0.000491	0.00142	CcSEcCtD
Risedronate—Flatulence—Rivastigmine—Alzheimer's disease	0.000489	0.00141	CcSEcCtD
Risedronate—Cough—Donepezil—Alzheimer's disease	0.000488	0.00141	CcSEcCtD
Risedronate—Hypertension—Donepezil—Alzheimer's disease	0.000483	0.00139	CcSEcCtD
Risedronate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000481	0.00139	CcSEcCtD
Risedronate—Back pain—Rivastigmine—Alzheimer's disease	0.00048	0.00139	CcSEcCtD
Risedronate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000477	0.00138	CcSEcCtD
Risedronate—Arthralgia—Donepezil—Alzheimer's disease	0.000476	0.00137	CcSEcCtD
Risedronate—Myalgia—Donepezil—Alzheimer's disease	0.000476	0.00137	CcSEcCtD
Risedronate—Chest pain—Donepezil—Alzheimer's disease	0.000476	0.00137	CcSEcCtD
Risedronate—Anxiety—Donepezil—Alzheimer's disease	0.000474	0.00137	CcSEcCtD
Risedronate—Anaemia—Memantine—Alzheimer's disease	0.000469	0.00135	CcSEcCtD
Risedronate—Dry mouth—Donepezil—Alzheimer's disease	0.000466	0.00134	CcSEcCtD
Risedronate—Body temperature increased—Galantamine—Alzheimer's disease	0.000465	0.00134	CcSEcCtD
Risedronate—Abdominal pain—Galantamine—Alzheimer's disease	0.000465	0.00134	CcSEcCtD
Risedronate—Anaemia—Rivastigmine—Alzheimer's disease	0.000459	0.00132	CcSEcCtD
Risedronate—Vertigo—Memantine—Alzheimer's disease	0.000456	0.00132	CcSEcCtD
Risedronate—Syncope—Memantine—Alzheimer's disease	0.000455	0.00131	CcSEcCtD
Risedronate—FDPS—Metabolism—DHCR24—Alzheimer's disease	0.000454	0.00697	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—MEF2C—Alzheimer's disease	0.000454	0.00696	CbGpPWpGaD
Risedronate—Infection—Donepezil—Alzheimer's disease	0.000453	0.00131	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—BCL2—Alzheimer's disease	0.000451	0.00693	CbGpPWpGaD
Risedronate—Shock—Donepezil—Alzheimer's disease	0.000449	0.0013	CcSEcCtD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM1—Alzheimer's disease	0.000448	0.00687	CbGpPWpGaD
Risedronate—Nervous system disorder—Donepezil—Alzheimer's disease	0.000447	0.00129	CcSEcCtD
Risedronate—Vertigo—Rivastigmine—Alzheimer's disease	0.000446	0.00129	CcSEcCtD
Risedronate—Loss of consciousness—Memantine—Alzheimer's disease	0.000446	0.00129	CcSEcCtD
Risedronate—Syncope—Rivastigmine—Alzheimer's disease	0.000445	0.00129	CcSEcCtD
Risedronate—Cough—Memantine—Alzheimer's disease	0.000443	0.00128	CcSEcCtD
Risedronate—Hypertension—Memantine—Alzheimer's disease	0.000438	0.00127	CcSEcCtD
Risedronate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000436	0.00126	CcSEcCtD
Risedronate—Hypersensitivity—Galantamine—Alzheimer's disease	0.000434	0.00125	CcSEcCtD
Risedronate—Cough—Rivastigmine—Alzheimer's disease	0.000433	0.00125	CcSEcCtD
Risedronate—Myalgia—Memantine—Alzheimer's disease	0.000432	0.00125	CcSEcCtD
Risedronate—Arthralgia—Memantine—Alzheimer's disease	0.000432	0.00125	CcSEcCtD
Risedronate—Chest pain—Memantine—Alzheimer's disease	0.000432	0.00125	CcSEcCtD
Risedronate—Anxiety—Memantine—Alzheimer's disease	0.000431	0.00124	CcSEcCtD
Risedronate—Hypertension—Rivastigmine—Alzheimer's disease	0.000429	0.00124	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000424	0.0065	CbGpPWpGaD
Risedronate—Myalgia—Rivastigmine—Alzheimer's disease	0.000423	0.00122	CcSEcCtD
Risedronate—Chest pain—Rivastigmine—Alzheimer's disease	0.000423	0.00122	CcSEcCtD
Risedronate—Arthralgia—Rivastigmine—Alzheimer's disease	0.000423	0.00122	CcSEcCtD
Risedronate—Dry mouth—Memantine—Alzheimer's disease	0.000423	0.00122	CcSEcCtD
Risedronate—Asthenia—Galantamine—Alzheimer's disease	0.000422	0.00122	CcSEcCtD
Risedronate—Anxiety—Rivastigmine—Alzheimer's disease	0.000421	0.00122	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00042	0.00121	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000416	0.0012	CcSEcCtD
Risedronate—PTGS2—nervous system—Alzheimer's disease	0.000415	0.0317	CbGeAlD
Risedronate—Dry mouth—Rivastigmine—Alzheimer's disease	0.000413	0.00119	CcSEcCtD
Risedronate—Insomnia—Donepezil—Alzheimer's disease	0.000413	0.00119	CcSEcCtD
Risedronate—Infection—Memantine—Alzheimer's disease	0.000412	0.00119	CcSEcCtD
Risedronate—Paraesthesia—Donepezil—Alzheimer's disease	0.00041	0.00118	CcSEcCtD
Risedronate—Shock—Memantine—Alzheimer's disease	0.000408	0.00118	CcSEcCtD
Risedronate—Dyspnoea—Donepezil—Alzheimer's disease	0.000407	0.00117	CcSEcCtD
Risedronate—Nervous system disorder—Memantine—Alzheimer's disease	0.000406	0.00117	CcSEcCtD
Risedronate—Diarrhoea—Galantamine—Alzheimer's disease	0.000403	0.00116	CcSEcCtD
Risedronate—Infection—Rivastigmine—Alzheimer's disease	0.000403	0.00116	CcSEcCtD
Risedronate—Skin disorder—Memantine—Alzheimer's disease	0.000402	0.00116	CcSEcCtD
Risedronate—Dyspepsia—Donepezil—Alzheimer's disease	0.000402	0.00116	CcSEcCtD
Risedronate—PTGS2—central nervous system—Alzheimer's disease	0.000399	0.0305	CbGeAlD
Risedronate—Shock—Rivastigmine—Alzheimer's disease	0.000399	0.00115	CcSEcCtD
Risedronate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000397	0.00115	CcSEcCtD
Risedronate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000394	0.00114	CcSEcCtD
Risedronate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000394	0.00114	CcSEcCtD
Risedronate—Fatigue—Donepezil—Alzheimer's disease	0.000393	0.00114	CcSEcCtD
Risedronate—PTGS2—cerebellum—Alzheimer's disease	0.00039	0.0298	CbGeAlD
Risedronate—Constipation—Donepezil—Alzheimer's disease	0.00039	0.00113	CcSEcCtD
Risedronate—Pain—Donepezil—Alzheimer's disease	0.00039	0.00113	CcSEcCtD
Risedronate—Dizziness—Galantamine—Alzheimer's disease	0.000389	0.00112	CcSEcCtD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—Alzheimer's disease	0.000388	0.00595	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CA4—Alzheimer's disease	0.000386	0.00593	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000378	0.0058	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000377	0.00109	CcSEcCtD
Risedronate—Insomnia—Memantine—Alzheimer's disease	0.000375	0.00108	CcSEcCtD
Risedronate—Vomiting—Galantamine—Alzheimer's disease	0.000374	0.00108	CcSEcCtD
Risedronate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000373	0.00108	CcSEcCtD
Risedronate—Paraesthesia—Memantine—Alzheimer's disease	0.000372	0.00107	CcSEcCtD
Risedronate—Rash—Galantamine—Alzheimer's disease	0.000371	0.00107	CcSEcCtD
Risedronate—Dermatitis—Galantamine—Alzheimer's disease	0.000371	0.00107	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—MPO—Alzheimer's disease	0.00037	0.00568	CbGpPWpGaD
Risedronate—Dyspnoea—Memantine—Alzheimer's disease	0.000369	0.00107	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000369	0.00107	CcSEcCtD
Risedronate—Headache—Galantamine—Alzheimer's disease	0.000369	0.00106	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—LPL—Alzheimer's disease	0.000368	0.00565	CbGpPWpGaD
Risedronate—Insomnia—Rivastigmine—Alzheimer's disease	0.000367	0.00106	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—Alzheimer's disease	0.000366	0.00562	CbGpPWpGaD
Risedronate—Dyspepsia—Memantine—Alzheimer's disease	0.000365	0.00105	CcSEcCtD
Risedronate—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000364	0.00105	CcSEcCtD
Risedronate—FDPS—Metabolism—GAPDHS—Alzheimer's disease	0.000363	0.00558	CbGpPWpGaD
Risedronate—Urticaria—Donepezil—Alzheimer's disease	0.000362	0.00105	CcSEcCtD
Risedronate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000361	0.00104	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—GFAP—Alzheimer's disease	0.000361	0.00555	CbGpPWpGaD
Risedronate—Abdominal pain—Donepezil—Alzheimer's disease	0.000361	0.00104	CcSEcCtD
Risedronate—Body temperature increased—Donepezil—Alzheimer's disease	0.000361	0.00104	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—Alzheimer's disease	0.000358	0.00549	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000358	0.00103	CcSEcCtD
Risedronate—Fatigue—Memantine—Alzheimer's disease	0.000357	0.00103	CcSEcCtD
Risedronate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000357	0.00103	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—MPO—Alzheimer's disease	0.000357	0.00547	CbGpPWpGaD
Risedronate—Constipation—Memantine—Alzheimer's disease	0.000354	0.00102	CcSEcCtD
Risedronate—Pain—Memantine—Alzheimer's disease	0.000354	0.00102	CcSEcCtD
Risedronate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00035	0.00101	CcSEcCtD
Risedronate—Nausea—Galantamine—Alzheimer's disease	0.00035	0.00101	CcSEcCtD
Risedronate—Fatigue—Rivastigmine—Alzheimer's disease	0.000349	0.00101	CcSEcCtD
Risedronate—Pain—Rivastigmine—Alzheimer's disease	0.000347	0.001	CcSEcCtD
Risedronate—Constipation—Rivastigmine—Alzheimer's disease	0.000347	0.001	CcSEcCtD
Risedronate—FDPS—Metabolism—ATP5A1—Alzheimer's disease	0.000344	0.00529	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—PPP3CA—Alzheimer's disease	0.000339	0.0052	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000339	0.000978	CcSEcCtD
Risedronate—PTGS2—S1P1 pathway—VEGFA—Alzheimer's disease	0.000338	0.00518	CbGpPWpGaD
Risedronate—Hypersensitivity—Donepezil—Alzheimer's disease	0.000336	0.00097	CcSEcCtD
Risedronate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000331	0.000957	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—Alzheimer's disease	0.00033	0.00506	CbGpPWpGaD
Risedronate—Urticaria—Memantine—Alzheimer's disease	0.000329	0.00095	CcSEcCtD
Risedronate—FDPS—Metabolism—PLD3—Alzheimer's disease	0.000329	0.00504	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000329	0.00504	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—PTGS1—Alzheimer's disease	0.000328	0.00504	CbGpPWpGaD
Risedronate—Abdominal pain—Memantine—Alzheimer's disease	0.000328	0.000945	CcSEcCtD
Risedronate—Body temperature increased—Memantine—Alzheimer's disease	0.000328	0.000945	CcSEcCtD
Risedronate—Asthenia—Donepezil—Alzheimer's disease	0.000327	0.000945	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000325	0.00498	CbGpPWpGaD
Risedronate—Pruritus—Donepezil—Alzheimer's disease	0.000323	0.000932	CcSEcCtD
Risedronate—Urticaria—Rivastigmine—Alzheimer's disease	0.000322	0.000929	CcSEcCtD
Risedronate—FDPS—SREBP signalling—AKT1—Alzheimer's disease	0.000321	0.00492	CbGpPWpGaD
Risedronate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00032	0.000925	CcSEcCtD
Risedronate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00032	0.000925	CcSEcCtD
Risedronate—PTGS2—brain—Alzheimer's disease	0.000317	0.0242	CbGeAlD
Risedronate—FDPS—Metabolism—HSD17B10—Alzheimer's disease	0.000315	0.00483	CbGpPWpGaD
Risedronate—Diarrhoea—Donepezil—Alzheimer's disease	0.000312	0.000901	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000308	0.00472	CbGpPWpGaD
Risedronate—Hypersensitivity—Memantine—Alzheimer's disease	0.000305	0.000881	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP46A1—Alzheimer's disease	0.000303	0.00465	CbGpPWpGaD
Risedronate—Dizziness—Donepezil—Alzheimer's disease	0.000302	0.000871	CcSEcCtD
Risedronate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000299	0.000862	CcSEcCtD
Risedronate—Asthenia—Memantine—Alzheimer's disease	0.000297	0.000858	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—Alzheimer's disease	0.000295	0.00452	CbGpPWpGaD
Risedronate—Pruritus—Memantine—Alzheimer's disease	0.000293	0.000846	CcSEcCtD
Risedronate—FDPS—Metabolism—ND1—Alzheimer's disease	0.000293	0.00449	CbGpPWpGaD
Risedronate—Asthenia—Rivastigmine—Alzheimer's disease	0.000291	0.000839	CcSEcCtD
Risedronate—Vomiting—Donepezil—Alzheimer's disease	0.00029	0.000837	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM1—Alzheimer's disease	0.00029	0.00444	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—Alzheimer's disease	0.000289	0.00444	CbGpPWpGaD
Risedronate—Rash—Donepezil—Alzheimer's disease	0.000288	0.00083	CcSEcCtD
Risedronate—Dermatitis—Donepezil—Alzheimer's disease	0.000287	0.00083	CcSEcCtD
Risedronate—Pruritus—Rivastigmine—Alzheimer's disease	0.000287	0.000828	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000286	0.00439	CbGpPWpGaD
Risedronate—Headache—Donepezil—Alzheimer's disease	0.000286	0.000825	CcSEcCtD
Risedronate—Diarrhoea—Memantine—Alzheimer's disease	0.000283	0.000818	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—ABCA1—Alzheimer's disease	0.000279	0.00428	CbGpPWpGaD
Risedronate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000277	0.000801	CcSEcCtD
Risedronate—Dizziness—Memantine—Alzheimer's disease	0.000274	0.000791	CcSEcCtD
Risedronate—Nausea—Donepezil—Alzheimer's disease	0.000271	0.000782	CcSEcCtD
Risedronate—Dizziness—Rivastigmine—Alzheimer's disease	0.000268	0.000774	CcSEcCtD
Risedronate—Vomiting—Memantine—Alzheimer's disease	0.000263	0.00076	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000262	0.00402	CbGpPWpGaD
Risedronate—Rash—Memantine—Alzheimer's disease	0.000261	0.000754	CcSEcCtD
Risedronate—Dermatitis—Memantine—Alzheimer's disease	0.000261	0.000753	CcSEcCtD
Risedronate—Headache—Memantine—Alzheimer's disease	0.00026	0.000749	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—PPP3CA—Alzheimer's disease	0.000258	0.00396	CbGpPWpGaD
Risedronate—Vomiting—Rivastigmine—Alzheimer's disease	0.000258	0.000744	CcSEcCtD
Risedronate—Rash—Rivastigmine—Alzheimer's disease	0.000256	0.000738	CcSEcCtD
Risedronate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000255	0.000737	CcSEcCtD
Risedronate—Headache—Rivastigmine—Alzheimer's disease	0.000254	0.000733	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Alzheimer's disease	0.000251	0.00386	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SOD1—Alzheimer's disease	0.000249	0.00382	CbGpPWpGaD
Risedronate—Nausea—Memantine—Alzheimer's disease	0.000246	0.00071	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000244	0.00375	CbGpPWpGaD
Risedronate—Nausea—Rivastigmine—Alzheimer's disease	0.000241	0.000695	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—Alzheimer's disease	0.000234	0.00358	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000229	0.00351	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000226	0.00346	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SOD2—Alzheimer's disease	0.000224	0.00344	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NGFR—Alzheimer's disease	0.000212	0.00326	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000211	0.00324	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000205	0.00315	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000205	0.00315	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Alzheimer's disease	0.000199	0.00305	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—MTHFR—Alzheimer's disease	0.000197	0.00303	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000192	0.00294	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CHAT—Alzheimer's disease	0.000189	0.0029	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TPI1—Alzheimer's disease	0.000189	0.0029	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000188	0.00289	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—BDNF—Alzheimer's disease	0.000185	0.00284	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—Alzheimer's disease	0.000184	0.00282	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MAOB—Alzheimer's disease	0.000181	0.00278	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1A—Alzheimer's disease	0.000177	0.00272	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000177	0.00271	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GAPDH—Alzheimer's disease	0.000174	0.00267	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—F2—Alzheimer's disease	0.000173	0.00266	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000172	0.00264	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000171	0.00262	CbGpPWpGaD
Risedronate—FDPS—Metabolism—A2M—Alzheimer's disease	0.000168	0.00258	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000167	0.00256	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000166	0.00256	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000164	0.00252	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000163	0.0025	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—INS—Alzheimer's disease	0.000157	0.00241	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	0.000157	0.0024	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	0.000154	0.00237	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.00015	0.0023	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ACHE—Alzheimer's disease	0.000146	0.00225	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—LEP—Alzheimer's disease	0.000145	0.00223	CbGpPWpGaD
Risedronate—FDPS—Metabolism—INPP5D—Alzheimer's disease	0.000145	0.00222	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000143	0.00219	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—BCL2—Alzheimer's disease	0.000137	0.00211	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS1—Alzheimer's disease	0.000137	0.0021	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ENO1—Alzheimer's disease	0.000137	0.0021	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—Alzheimer's disease	0.000135	0.00208	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP2D6—Alzheimer's disease	0.000134	0.00206	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Alzheimer's disease	0.000133	0.00205	CbGpPWpGaD
Risedronate—PTGS2—Disease—ITM2B—Alzheimer's disease	0.00013	0.00199	CbGpPWpGaD
Risedronate—FDPS—Metabolism—BCHE—Alzheimer's disease	0.000127	0.00196	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000126	0.00193	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	0.000122	0.00187	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PLCB1—Alzheimer's disease	0.00012	0.00185	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000118	0.00181	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	0.000117	0.0018	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000117	0.0018	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCA1—Alzheimer's disease	0.000117	0.00179	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DHCR24—Alzheimer's disease	0.000109	0.00167	CbGpPWpGaD
Risedronate—PTGS2—Disease—GAPDHS—Alzheimer's disease	0.000104	0.00159	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000101	0.00156	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARGC1A—Alzheimer's disease	0.0001	0.00154	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMOX1—Alzheimer's disease	0.0001	0.00154	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	9.43e-05	0.00145	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	9.26e-05	0.00142	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CA4—Alzheimer's disease	9.26e-05	0.00142	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	9.23e-05	0.00142	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LPL—Alzheimer's disease	9.15e-05	0.0014	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	9.05e-05	0.00139	CbGpPWpGaD
Risedronate—PTGS2—Disease—TTR—Alzheimer's disease	9.01e-05	0.00138	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	8.7e-05	0.00134	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	8.49e-05	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	8.48e-05	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	8.25e-05	0.00127	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTHFR—Alzheimer's disease	8.24e-05	0.00126	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	8.16e-05	0.00125	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLD3—Alzheimer's disease	7.87e-05	0.00121	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	7.87e-05	0.00121	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	7.78e-05	0.00119	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CALM1—Alzheimer's disease	7.7e-05	0.00118	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOE—Alzheimer's disease	7.67e-05	0.00118	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CAV1—Alzheimer's disease	7.6e-05	0.00117	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	7.54e-05	0.00116	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.37e-05	0.00113	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	7.26e-05	0.00111	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	7.19e-05	0.0011	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	7.12e-05	0.00109	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ND1—Alzheimer's disease	7.01e-05	0.00108	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	6.86e-05	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	6.85e-05	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	6.72e-05	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Disease—SNCA—Alzheimer's disease	6.7e-05	0.00103	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—Alzheimer's disease	6.68e-05	0.00103	CbGpPWpGaD
Risedronate—FDPS—Metabolism—INS—Alzheimer's disease	6.55e-05	0.00101	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	6.28e-05	0.000964	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.27e-05	0.000962	CbGpPWpGaD
Risedronate—PTGS2—Disease—PSENEN—Alzheimer's disease	5.97e-05	0.000916	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	5.92e-05	0.000909	CbGpPWpGaD
Risedronate—PTGS2—Disease—APH1A—Alzheimer's disease	5.88e-05	0.000903	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	5.77e-05	0.000886	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NOS3—Alzheimer's disease	5.75e-05	0.000882	CbGpPWpGaD
Risedronate—PTGS2—Disease—NCSTN—Alzheimer's disease	5.73e-05	0.000879	CbGpPWpGaD
Risedronate—PTGS2—Disease—LRP1—Alzheimer's disease	5.59e-05	0.000858	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	5.42e-05	0.000832	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.4e-05	0.000829	CbGpPWpGaD
Risedronate—PTGS2—Disease—TPI1—Alzheimer's disease	5.4e-05	0.000828	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	5.33e-05	0.000818	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—Alzheimer's disease	5.25e-05	0.000806	CbGpPWpGaD
Risedronate—PTGS2—Disease—EIF2AK2—Alzheimer's disease	5.07e-05	0.000779	CbGpPWpGaD
Risedronate—PTGS2—Disease—GAPDH—Alzheimer's disease	4.98e-05	0.000764	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.92e-05	0.000755	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	4.89e-05	0.000751	CbGpPWpGaD
Risedronate—PTGS2—Disease—PSEN2—Alzheimer's disease	4.66e-05	0.000715	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	4.57e-05	0.000701	CbGpPWpGaD
Risedronate—PTGS2—Disease—CST3—Alzheimer's disease	4.56e-05	0.000699	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CHAT—Alzheimer's disease	4.52e-05	0.000694	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TPI1—Alzheimer's disease	4.52e-05	0.000694	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MAOB—Alzheimer's disease	4.33e-05	0.000665	CbGpPWpGaD
Risedronate—PTGS2—Disease—IAPP—Alzheimer's disease	4.26e-05	0.000654	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GAPDH—Alzheimer's disease	4.17e-05	0.00064	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.12e-05	0.000633	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.09e-05	0.000627	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—A2M—Alzheimer's disease	4.03e-05	0.000618	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.03e-05	0.000618	CbGpPWpGaD
Risedronate—PTGS2—Disease—ENO1—Alzheimer's disease	3.92e-05	0.000602	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP3CA—Alzheimer's disease	3.9e-05	0.000599	CbGpPWpGaD
Risedronate—PTGS2—Disease—GAB2—Alzheimer's disease	3.74e-05	0.000574	CbGpPWpGaD
Risedronate—PTGS2—Disease—GSK3A—Alzheimer's disease	3.71e-05	0.000569	CbGpPWpGaD
Risedronate—PTGS2—Disease—APP—Alzheimer's disease	3.65e-05	0.000559	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.59e-05	0.000551	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ACHE—Alzheimer's disease	3.5e-05	0.000538	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—INPP5D—Alzheimer's disease	3.46e-05	0.000532	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	3.4e-05	0.000522	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ENO1—Alzheimer's disease	3.28e-05	0.000504	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTGS1—Alzheimer's disease	3.28e-05	0.000504	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	3.22e-05	0.000494	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADAM10—Alzheimer's disease	3.13e-05	0.000481	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BCHE—Alzheimer's disease	3.05e-05	0.000469	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLCB1—Alzheimer's disease	2.88e-05	0.000442	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCA1—Alzheimer's disease	2.79e-05	0.000429	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—Alzheimer's disease	2.64e-05	0.000405	CbGpPWpGaD
Risedronate—PTGS2—Disease—LPL—Alzheimer's disease	2.62e-05	0.000402	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRKCG—Alzheimer's disease	2.54e-05	0.00039	CbGpPWpGaD
Risedronate—PTGS2—Disease—CCR5—Alzheimer's disease	2.41e-05	0.00037	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	2.41e-05	0.000369	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—Alzheimer's disease	2.4e-05	0.000368	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—Alzheimer's disease	2.36e-05	0.000362	CbGpPWpGaD
Risedronate—PTGS2—Disease—CALM1—Alzheimer's disease	2.2e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOE—Alzheimer's disease	2.19e-05	0.000337	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LPL—Alzheimer's disease	2.19e-05	0.000336	CbGpPWpGaD
Risedronate—PTGS2—Disease—CAV1—Alzheimer's disease	2.17e-05	0.000333	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—Alzheimer's disease	2.04e-05	0.000314	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOTCH1—Alzheimer's disease	2.02e-05	0.000311	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—Alzheimer's disease	1.97e-05	0.000303	CbGpPWpGaD
Risedronate—PTGS2—Disease—GSK3B—Alzheimer's disease	1.9e-05	0.000291	CbGpPWpGaD
Risedronate—PTGS2—Disease—CREB1—Alzheimer's disease	1.88e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Disease—INS—Alzheimer's disease	1.87e-05	0.000288	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CALM1—Alzheimer's disease	1.84e-05	0.000283	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOE—Alzheimer's disease	1.84e-05	0.000282	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAV1—Alzheimer's disease	1.82e-05	0.000279	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS3—Alzheimer's disease	1.64e-05	0.000252	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—Alzheimer's disease	1.6e-05	0.000246	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—INS—Alzheimer's disease	1.57e-05	0.000241	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NOS3—Alzheimer's disease	1.38e-05	0.000211	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—Alzheimer's disease	1.09e-05	0.000167	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—Alzheimer's disease	8.19e-06	0.000126	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—Alzheimer's disease	7.55e-06	0.000116	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—Alzheimer's disease	6.33e-06	9.71e-05	CbGpPWpGaD
